35 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for Adaptimmune or TCR2’s product
425
TCRR
Tcr2 Therapeutics Inc
30 May 23
Business combination disclosure
4:21pm
of Adaptimmune’s or TCR2’s patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for Adaptimmune
8-K
ADAP
Adaptimmune Therapeutics plc
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
of the supply chain for raw materials or manufacturing for Adaptimmune or TCR2’s product candidates, the nature, timing, cost and possible success and therapeutic
425
ADAP
Adaptimmune Therapeutics plc
22 May 23
Business combination disclosure
7:01am
of Adaptimmune’s or TCR2’s patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing
8-K
wvsak19wah5wy mbwzk
22 May 23
Other Events
6:59am
8-K
EX-99.1
cq0fyauw
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am